The Impact of Conversion From Prograf to Generic Tacrolimus in Liver and Kidney Transplant Recipients With Stable Graft Function
Open Access
- 30 June 2011
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 11 (9) , 1861-1867
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Immunosuppression: evolution in practice and trends, 1993–2003American Journal of Transplantation, 2005
- C2 (2-h) levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal-transplant patientsNephrology Dialysis Transplantation, 2002
- Payment for Immunosuppression After Organ TransplantationJAMA, 2000
- Profiles of noncompliance in patients with a functioning renal transplant: a multicenter studyTransplantation Proceedings, 1999
- RELATIONSHIP OF FK506 WHOLE BLOOD CONCENTRATIONS AND EFFICACY AND TOXICITY AFTER LIVER AND KIDNEY TRANSPLANTATIONTransplantation, 1996
- Consensus Document: Therapeutic Monitoring of Tacrolimus (FK-506)Therapeutic Drug Monitoring, 1995
- MEDICATION COMPLIANCE AFTER RENAL TRANSPLANTATIONTransplantation, 1995
- INCIDENCE, DETERMINANTS, AND CONSEQUENCES OF SUBCLINICAL NONCOMPLIANCE WITH IMMUNOSUPPRESSIVE THERAPY IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1995
- A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver TransplantationNew England Journal of Medicine, 1994
- NONCOMPLIANCE IN ORGAN TRANSPLANT RECIPIENTSTransplantation, 1990